Medulloblastoma: Clinical Trials

15 trials for Medulloblastoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 recruiting, 2 terminated, 1 active not recruiting. 15 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 315Completed 9, Recruiting 2, Terminated 2, Active not recruiting 1, Not yet recruiting 1
Phase 22Active not recruiting 1, Completed 1

Follow Medulloblastoma: new trials by email Literature Review of Medulloblastoma trials Research Report on Medulloblastoma

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
Bridging Chemotherapy, Induction Cycles A1-A3, Induction Cycles A4-5 - Medulloblastoma
Phase 3Not yet recruitingNationwide Children's Hospital962027-01-012026-10-20
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Audiometric Test, Auditory Brainstem Response, Biospecimen Collection - Childhood Medulloblastoma
Phase 3RecruitingChildren's Oncology Group2252023-02-202026-08-25
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
Metformin hydrochloride (HCl) 500mg tablet, Placebo - Medulloblastoma, Childhood, Cognitive Impairment
Phase 3RecruitingDonald Mabbott1402022-07-012026-09-24
Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma
Metformin, Placebo - Brain Tumor Treated With Cranial or Cranial-Spinal Radiation
Phase 3CompletedThe Hospital for Sick Children242014-06-132026-09-24
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
Radiotherapy without Carboplatin, Reduced-intensity maintenance chemotherapy, Radiotherapy with Carboplatin - Brain Tumors
Phase 2 / Phase 3Active not recruitingUniversitätsklinikum Hamburg-Eppendorf3602014-06-012025-12-04
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
filgrastim - Childhood Choroid Plexus Tumor, Childhood Medulloblastoma
Phase 3TerminatedBarbara Ann Karmanos Cancer Institute232013-08-012020-10-29
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
cyproheptadine hydrochloride, placebo - Cancer
Phase 3TerminatedUniversity of South Florida222010-06-012015-07-02
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
sodium thiosulfate, examination - Brain Tumor, Central Nervous System Tumor
Phase 3CompletedChildren's Oncology Group1312008-06-232023-11-09
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
donepezil hydrochloride, Placebo - Brain Tumors, Metastatic Disease
Phase 3CompletedWake Forest University Health Sciences1982008-02-012021-10-20
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
Autologous Hematopoietic Stem Cell Transplantation, Carboplatin, Cisplatin - Anaplastic Medulloblastoma, Medulloblastoma
Phase 3CompletedChildren's Oncology Group912007-10-222026-01-23
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Fentanyl sublingual spray, Placebo - Cancer
Phase 3CompletedINSYS Therapeutics Inc1302007-10-012014-03-05
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET
Biospecimen Collection, Carboplatin, Cisplatin - Anaplastic Medulloblastoma, Medulloblastoma
Phase 3CompletedChildren's Oncology Group3792007-05-232026-06-08
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
carboplatin, etoposide, temozolomide - Recurrent Brain Tumors, Supratentorial PNETs
Phase 2 / Phase 3CompletedUniversity Hospital, Bonn1742006-02-012018-07-20
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
Cisplatin, Craniospinal Irradiation, Cyclophosphamide - Medulloblastoma
Phase 3CompletedChildren's Oncology Group5492004-04-302026-06-09
Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma (PNET4)
Standard Fractionation Regimen, Hyperfractionated Radiotherapy - Medulloblastoma
Phase 3CompletedInstitut Curie522004-04-012025-09-15

Narrower conditions

Brain Neoplasms (5)  ·  Choroid Plexus Neoplasms (4)  ·  Osteosarcoma (4)  ·  Astrocytoma (3)  ·  Ependymoma (3)  ·  Glioblastoma (3)  ·  Neuroblastoma (3)  ·  Neuroectodermal Tumors, Primitive (3)  ·  Oligodendroglioma (3)  ·  Sarcoma (3)  ·  Testicular Neoplasms (3)  ·  Chondrosarcoma (2)  ·  Craniopharyngioma (2)  ·  Glioma (2)

Broader conditions

Neoplasms by Histologic Type (15)  ·  Neoplasms, Germ Cell and Embryonal (15)  ·  Neoplasms, Glandular and Epithelial (15)  ·  Neoplasms, Nerve Tissue (15)  ·  Neuroectodermal Tumors (15)  ·  Neoplasms, Neuroepithelial (14)  ·  Glioma (13)  ·  Neoplasms (13)  ·  Neuroectodermal Tumors, Primitive (12)  ·  Brain Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Neoplasms by Site (7)  ·  Nervous System Diseases (7)  ·  Nervous System Neoplasms (7)  ·  Central Nervous System Neoplasms (6)

Interventions

Cisplatin (5)  ·  Cyclophosphamide (5)  ·  Vincristine (5)  ·  1,2-diaminocyclohexaneplatinum II citrate (4)  ·  Carboplatin (4)  ·  Platinum (4)  ·  Radiotherapy (4)  ·  Filgrastim (3)  ·  Granulocyte Colony-Stimulating Factor (3)  ·  Lomustine (3)  ·  Radiation (3)  ·  Etoposide (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Metformin (2)  ·  Specimen Handling (2)

Sponsors

Children's Oncology Group (5)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Donald Mabbott (1)  ·  INSYS Therapeutics Inc (1)  ·  Institut Curie (1)  ·  Nationwide Children's Hospital (1)  ·  The Hospital for Sick Children (1)  ·  University Hospital, Bonn (1)  ·  University of South Florida (1)  ·  Universitätsklinikum Hamburg-Eppendorf (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (10)  ·  Canada (7)  ·  Australia (5)  ·  Netherlands (3)  ·  Puerto Rico (3)  ·  France (2)  ·  Germany (2)  ·  Switzerland (2)  ·  Austria (1)  ·  Belgium (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Ireland (1)  ·  Italy (1)  ·  New Zealand (1)

Top investigators

Claire M Mazewski (1)  ·  David R. Freyer, DO, MS (1)  ·  Donald Mabbott, Ph.D. (1)  ·  Donald Mabbott, PhD (1)  ·  Eric Bouffet, M.D. (1)  ·  Francois Doz, Prof. Dr. (1)  ·  Girish Dhall, MD (1)  ·  Gudrun Fleischhack, MD (1)  ·  Jeff M Michalski (1)  ·  Jeffrey P. Krischer, PhD (1)  ·  Larry Dillaha, MD (1)  ·  Maryam Fouladi, MD (1)  ·  Maxim Yankelevich (1)  ·  Ralph Salloum (1)

Results publications

PMID 22480131, PMID 27020837, PMID 27914822, PMID 30332335, PMID 30392813, PMID 32719487, PMID 34110925, PMID 34292305, PMID 40515500, PMID 40967259

NIH funding

U10CA180886 (4), U10CA098543 (3), P30CA022453 (1), R01CA114567 (1), U10CA081851 (1), U10CA081920 (1)